First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study

Yahua Wua Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaView further author information

Bin Dua Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaView further author information

Chengliu Lva Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaView further author information

Xiaohui Jib Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, ChinaView further author information

Yanqin Lana Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaView further author information

Na Yaoa Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaView further author information

Yingjiao Zhua Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaView further author information

Jinhuo Laia Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, ChinaCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window